Home > > > Risk/benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Risk/benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

0 stars by 0 votes
Google Book Preview of Risk/benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Best Price: Rs. 20,735 - Rs. 20,735 Compare prices from 1 sellers »

Book Details

Format
Binding Hardback
Overview
Publisher Kluwer Academic Publishers

Risk/benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents Price in India

RediffBooks

Return Policy
Cash on Delivery ; EMI

20,735.00 Rs. 20,735 + FREE Shipping

Local stores for Books

or Find Shops Near Me
Shop NameAddressDistancePhone NumberMap & Direction
Does your store sale this book?
ADD YOUR STORE

Google Preview

Price Alert